Low serum albumin level deteriorates prognosis in azacitidine-treated myelodysplastic syndromes patients – results of the PALG study ‘PolAZA’-Reference-Cited by-同舟云学术

Low serum albumin level deteriorates prognosis in azacitidine-treated myelodysplastic syndromes patients – results of the PALG study ‘PolAZA’

Published:2021-01-01 Issue:1 Volume:26 Page:556-564
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Mądry Krzysztof¹,Lis Karol¹,Tukiendorf Andrzej²,Szwedyk Paweł³,Kapelko-Słowik Katarzyna⁴,Subocz Edyta⁵,Gołos Aleksandra⁶,Makowska Wioletta⁶,Masternak Anna⁷,Kopińska Anna⁸,Czemerska Magdalena⁹,Zawadzka-Leska Sara¹,Rusicka Patrycja¹,Drozd-Sokołowska Joanna¹^ORCID,Wiater Elżbieta¹⁰,Hołojda Jadwiga¹¹,Pogłódek Bartłomiej¹²,Centkowski Piotr¹³,Waszczuk-Gajda Anna¹^ORCID,Machowicz Rafał¹,Hałka Janusz⁵,Czerw Tomasz¹⁴,Basak Grzegorz¹^ORCID,Dwilewicz-Trojaczek Jadwiga¹^ORCID

Affiliation:

1. Department of Hematology, Oncology and Internal Diseases, Medical University, Warsaw, Poland

2. Department of Public Health, Wrocław Medical University, Wrocław, Poland

3. Department of Hematology, Voivodal Specialist Hospital, Kraków, Poland

4. Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, University Hospital, Wrocław, Poland

5. Department of Hematology, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration’s Hospital, Olsztyn, Poland

6. Department of Hematology, Institute of Hematology and Blood Transfusion, Warsaw, Poland

7. Department of Hematology and Hematooncology, District Specialist Hospital, Opole, Poland

8. Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland

9. Department of Hematology, Medical University of Łódź, Łódź, Poland

10. Department of Hematology, District Hospital in Toruń, Toruń, Poland

11. Department of Hematology, District Specialist Hospital in Legnica, Legnica, Poland

12. Department of Hematooncology, Specialist Hospital, Brzozów, Poland

13. Department of Hematology, District Specialist Hospital in Biała Podlaska, Biała Podlaska, Poland

14. Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Warszawa, Poland

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2021.1956182

Reference31 articles.

1. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

2. Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

3. The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group

4. Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia

5. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world practice-based prognostic model for higher-risk myelodysplastic syndromes treated with azacitidine monotherapy: The Kyoto prognostic scoring system;International Journal of Hematology;2023-06-28

3. Association between serum albumin and 60-day mortality in Chinese Hakka patients with non-APL acute myeloid leukemia: a retrospective cohort study;BMC Cancer;2022-11-03